Index 1-29, 1972-1976 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Index 1-29, 1972-1976 PDF full book. Access full book title Index 1-29, 1972-1976 by FAO. Water Resources and Development Service. Download full books in PDF and EPUB format.
Author: FAO. Water Resources and Development Service
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: FAO. Water Resources and Development Service
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Economic history
Languages : en
Pages : 692
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee to Investigate the Administration of the Internal Security Act and Other Security Laws
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 260
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Administrative law
Languages : en
Pages : 576
Get Book Here
Book Description
Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries.
Author: United States. Veterans Administration
Publisher:
ISBN:
Category : Government Publications
Languages : en
Pages : 580
Get Book Here
Book Description
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Meeting
Publisher: World Health Organization
ISBN: 9283212908
Category : Medical
Languages : en
Pages : 690
Get Book Here
Book Description
This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous Working Group (IARC, 1995). The monograph in the present volume incorporates new data that have become available during the past decade. HPVs represent the most common infectious agents that are transmitted sexually throughout the world; the major risk factors are behaviors associated with sexual activity. Although most infections are asymptomatic and are cleared within a period of 2 years, genital HPV infection can lead to clinical disease, including anogenital warts, cervical neoplasia, cervical cancer and other anogenital cancers. The risk for persistence of infection and progression of the more than 40 genital HPV types to grade 3 cervical intraepithelial neoplasia (CIN3) and cancer differs widely. Persistent infection with carcinogenic HPVs occurs in virtually all cases of cervical cancer. Previous evaluations of HPVs have classified types 16 and 18 as carcinogenic to humans (group 1), types 31 and 33 as probably carcinogenic to humans (Group 2A) and some types other than 16, 18, 31 and 33 as possibly carcinogenic to humans (Group 2B). At that time, the evaluation of types 16 and 18 was based on the strong association between infection with these HPVs and cervical cancer. For types 31 and 33, the association was less strong. The new epidemiological data reviewed in the present volume strongly support and further confirm the previous evaluation of types 16 and 18, and provide new evidence for other HPVs. This information, which includes strong evidence of carcinogenicity at sites other than the cervix, supports new evaluations for several other HPV types in addition to those mentioned above. Since the Working Group was convened in 2005, important innovations in HPV prophylaxis have occurred and these needed to be included in this volume. To date two prophylactic vaccines have been developed and used in large multicentric trials. This prophylactic vaccination is expected to reduce the incidence of HPV-related genital diseases. However, the benefits of prophylactic vaccines in a broad public health perspective will be achieved only if such vaccines can be provided to those groups of women for whom access to cervical cancer screening services is most problematic. Therefore, the development of second-generation vaccines that are expected to be cheaper, easier to deliver and to provide T-cell response against pre-existing HPV infections is highly desirable.
Author:
Publisher:
ISBN:
Category : Science
Languages : en
Pages : 988
Get Book Here
Book Description
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN: 9283212916
Category : Medical
Languages : en
Pages : 544
Get Book Here
Book Description
Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp.
Author:
Publisher:
ISBN:
Category : Labor
Languages : en
Pages : 644
Get Book Here
Book Description
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: IARC
ISBN: 9789283212836
Category : Medical
Languages : en
Pages : 1476
Get Book Here
Book Description
The IARC Monographs series publishes authoritative independent assessments by international experts of the carcinogenic risks posed to humans by a variety of agents, mixtures and exposures. They are a resource of information for both researchers and national and international authorities. This volume is particularly significant because tobacco smoke not only causes more deaths from cancer than any other known agent; it also causes more deaths from vascular and respiratory diseases. This volume contains all the relevant information on both direct and passive smoking. It is organised by first looking at the nature of agent before collecting the evidence of cancer in humans. This is followed by carcinogenicity studies on animals and then any other data relevant to an evaluation.
